EGR3 and B-cell chronic lymphocytic leukemia: Additionally, HELQ and EGR3 expression levels were associated with the mutation status of the heavy chain variable region (IgHV) in patients with chronic lymphocytic leukemia (CLL), indicating that HELQ/EGR3 is a potential prognostic marker linked to targeted cell signaling pathways [68].